| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.07 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.07 |